Blue Earth and Seibersdorf expand radiopharmaceutical manufacture deal
Blue Earth Therapeutics' collaboration with Seibersdorf Labor will include the production of investigational 225Ac-based radioligand therapy.
Blue Earth Therapeutics' collaboration with Seibersdorf Labor will include the production of investigational 225Ac-based radioligand therapy.
What's Your Reaction?
